EMAIL THIS PAGE TO A FRIEND
PZ0260 Sigma-Aldrich

PF06691283

≥98% (HPLC)

Synonym: (4S,4aR,6R,8aS)-8a-(2,4-Difluoro-phenyl)-4-fluoromethyl-6-(4-methyl-oxazol-2-yl)-4,4a,5,6,8,8a-hexahydro-7-oxa-3-thia-1-aza-naphthalen-2-ylamine, PF-06691283

  • Empirical Formula (Hill Notation) C18H18F3N3O2S

  • Molecular Weight 397.41

  •  MDL number MFCD28580117

  •  PubChem Substance ID 329823796

Purchase

Properties

Related Categories Alzheimer′s Disease, Assays/Reagents for Alzheimer′s Disease Research, Bioactive Small Molecule Alphabetical Index, Bioactive Small Molecules, Cell Biology,
InChI Key   LKLYLZSFUBTUBW-KDQZPGIASA-N
assay   ≥98% (HPLC)
form   powder
color   white to beige
solubility   DMSO: 20 mg/mL, clear
originator   Pfizer
storage temp.   2-8°C

Description

Packaging

25 mg in glass bottle

Biochem/physiol Actions

PF06691283 is a new β-Secretase (BACE) inhibitor.

Other Notes

This compound was developed by Pfizer for Neuroscience research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer.

To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Legal Information

Sold for research purposes under agreement from Pfizer Inc.

Safety & Documentation

Safety Information

RIDADR 
NONH for all modes of transport

Documents

Certificate of Analysis (COA)

Please Enter a Lot Number
Protocols & Articles

Articles

Pfizer Compounds for Neuroscience

From our library of Articles, Sigma-Aldrich presents Pfizer Compounds for Neuroscience

Related Products

Technical Service:

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Bulk Ordering & Pricing:

Need larger quantities for your development, manufacturing or research applications?